Enzyme Inhibition Visualizer with MM & Lineweaver–Burk

You screened a compound library and found three hits that inhibit your target protease. The dose-response looks similar for all three, but the mechanisms could be completely different — competitive, noncompetitive, or uncompetitive — and the mechanism determines how the inhibitor will behave at physiological substrate concentrations. An enzyme inhibition visualizer takes your rate-versus-[S] data at multiple inhibitor concentrations, overlays the Michaelis–Menten and Lineweaver–Burk plots, and shows which kinetic parameters shift so you can classify the inhibition type.

The mistake that leads to wrong classification: running the inhibition assay at a single substrate concentration. You cannot distinguish competitive from noncompetitive inhibition without seeing how the rate changes across a range of [S] values. A competitive inhibitor looks identical to a noncompetitive inhibitor at one [S] — both reduce v. The diagnostic is how the apparent Km and Vmax shift, and you need a full v-vs-[S] curve with and without inhibitor to see that.

Competitive: The inhibitor competes with substrate for the active site. Adding more substrate can outcompete the inhibitor, so Vmax stays the same but the apparent Km increases. The enzyme needs more substrate to reach half-max velocity because some active sites are blocked by inhibitor at any given moment.

Noncompetitive: The inhibitor binds a site other than the active site and reduces catalytic activity whether or not substrate is bound. Km stays the same (substrate binding is unaffected) but Vmax drops. No amount of extra substrate can overcome the inhibition because the inhibitor does not compete with substrate.

Uncompetitive: The inhibitor binds only the enzyme–substrate complex, not the free enzyme. Both Km and Vmax decrease by the same factor, so the ratio Vmax/Km stays constant. On a Lineweaver–Burk plot, this produces parallel lines — the slopes are identical, but the intercepts shift.

These are the three pure types. Most real inhibitors are “mixed” — a blend of competitive and noncompetitive character — where both Km and Vmax change but not by the same factor.

The double-reciprocal plot (1/v vs. 1/[S]) turns the hyperbolic Michaelis–Menten curve into a straight line. Plot the uninhibited data and each inhibitor concentration as separate lines, and the intersection pattern tells you the inhibition type at a glance:

• Competitive: Lines intersect on the y-axis (same 1/Vmax). Slopes increase with [I].
• Noncompetitive: Lines intersect on the x-axis (same −1/Km). y-intercepts increase with [I].
• Uncompetitive: Parallel lines (same slope). Both intercepts shift upward with [I].
• Mixed: Lines intersect in the second quadrant (neither axis). Both slope and intercept change.

Use this plot for pattern recognition only, not for extracting Ki. The Lineweaver–Burk transformation amplifies error at low [S] (which becomes large 1/[S]), making the intersection point unreliable for quantitative work. Determine Ki from nonlinear regression against the appropriate inhibited-rate equation.

Mixed inhibition sits between competitive and noncompetitive: the inhibitor binds both free enzyme and the enzyme–substrate complex, but with different affinities. This introduces two constants — Ki (binding to free enzyme) and Ki′ (binding to E–S complex). The ratio α′ = 1 + [I]/Ki′ affects Vmax, while α = 1 + [I]/Ki affects Km.

When Ki = Ki′, mixed inhibition collapses to pure noncompetitive (equal affinity for E and ES). When Ki′ → ∞ (inhibitor does not bind ES at all), it collapses to pure competitive. Real inhibitors almost always have Ki ≠ Ki′, which is why mixed inhibition is more common in practice than the textbook pure types.

To fit mixed inhibition, you need data at three or more inhibitor concentrations plus uninhibited control, with each set spanning 6+ substrate concentrations. Fewer data points make it impossible to resolve Ki and Ki′ independently — the fitter will return wide confidence intervals or fail to converge.

The Lineweaver–Burk lines do not intersect cleanly at one point. What does that mean?
Experimental error. Perfect intersection at a single point requires perfect data. If the lines roughly converge near the y-axis, call it competitive. If they roughly converge near the x-axis, call it noncompetitive. If the intersection wanders into the second quadrant, call it mixed and fit the mixed model.

My competitive inhibitor has a Ki of 50 µM. Is that good?
Depends on the application. For a drug lead, 50 µM is weak — you typically want nanomolar Ki for therapeutic candidates. For a biochemical tool compound used at saturating concentrations in an assay, 50 µM is fine as long as you can add enough without solubility issues.

Can substrate inhibition look like an inhibitor on the plot?
Yes. If your highest [S] point falls in the substrate-inhibition zone, the rate drops and the double-reciprocal point curves upward, mimicking uncompetitive inhibition. Always run a no-inhibitor control across the full [S] range to establish the baseline curve before adding inhibitor data.

How many inhibitor concentrations do I need?
Three minimum (0, ~Ki, and 3×Ki), but four or five give better resolution. If you do not know Ki, start with 0, 1, 10, 100, and 1000 µM and narrow the range once you see where inhibition kicks in.

Each inhibition type modifies the Michaelis–Menten equation differently:

Units note: Ki and Ki′ have the same units as [I] (typically µM). α and α′ are dimensionless. When [I] = 0, all equations reduce to the uninhibited Michaelis–Menten form.

Scenario: You are characterizing a competitive inhibitor of alkaline phosphatase. Km (uninhibited) = 200 µM, Vmax = 50 µM/min. You ran v-vs-[S] curves at [I] = 0, 100, and 300 µM.

Step 1 — Apparent Km at each [I].
At [I] = 100: apparent Km = 400 µM (doubled). α = 400/200 = 2.
At [I] = 300: apparent Km = 800 µM (quadrupled). α = 800/200 = 4.

Step 2 — Extract Ki.
α = 1 + [I]/Ki. At [I] = 100: 2 = 1 + 100/Ki → Ki = 100 µM.
At [I] = 300: 4 = 1 + 300/Ki → Ki = 100 µM. Consistent — good.

Step 3 — Lineweaver–Burk check.
All three lines converge at the y-axis (1/Vmax = 0.02). Slopes increase with [I]: uninhibited slope = Km/Vmax = 4, [I] = 100 slope = 8, [I] = 300 slope = 16. Classic competitive pattern.

Step 4 — Practical implication.
Ki = 100 µM means at [I] = 100 µM, the enzyme needs twice as much substrate to reach half-max velocity. In a cell where [S] is fixed, the inhibitor effectively halves the rate. At [I] = 300 µM, the rate drops to ~25% at physiological [S].